Cargando…
Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN
Celecoxib, a COX-2 inhibitor and non-steroidal anti-inflammatory drug, can prevent several types of cancer, including hepatocellular carcinoma (HCC). Here we show that celecoxib suppressed the self-renewal and drug-pumping functions in HCC cells. Besides, celecoxib depleted CD44 + /CD133 + hepatic c...
Autores principales: | Chu, Tian-Huei, Chan, Hoi-Hung, Kuo, Hsiao-Mei, Liu, Li-Fen, Hu, Tsung-Hui, Sun, Cheuk-Kwan, Kung, Mei-Lang, Lin, Shih-Wei, Wang, E-Ming, Ma, Yi-Ling, Cheng, Kwan-Hung, Lai, Kwok Hung, Wen, Zhi-Hong, Hsu, Ping-I, Tai, Ming-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039225/ https://www.ncbi.nlm.nih.gov/pubmed/24721996 |
Ejemplares similares
-
Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
por: Chu, Tian‐Huei, et al.
Publicado: (2018) -
Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation
por: Chan, Hoi-Hung, et al.
Publicado: (2010) -
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis
por: Chen, San-Cher, et al.
Publicado: (2015) -
Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013) -
Correction: Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013)